【普利制药：触及重大违法强制退市 1月7日起被实施“退市风险警示”】普利制药(300630.SZ)发布公告，公司因涉嫌信息披露违法违规，被中国证监会立案调查。公司于2025年1月4日收到中国证监会下发的《行政处罚事先告知书》。

金融界01-05 16:23

普利制药(300630.SZ)发布公告，公司因涉嫌信息披露违法违规，被中国证监会立案调查。公司于2025年1月4日收到中国证监会下发的《行政处罚事先告知书》。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2501940114?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-05 16:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501940114","market":"hk","top_or_hot":-1,"title":"【普利制药：触及重大违法强制退市 1月7日起被实施“退市风险警示”】普利制药(300630.SZ)发布公告，公司因涉嫌信息披露违法违规，被中国证监会立案调查。公司于2025年1月4日收到中国证监会下发的《行政处罚事先告知书》。","media":"金融界","content":"<html><body><div><span><a href=\"https://laohu8.com/S/300630\">普利制药</a></span>(300630.SZ)发布公告，公司因涉嫌信息披露违法违规，被中国证监会立案调查。公司于2025年1月4日收到中国证监会下发的《行政处罚事先告知书》。</div></body></html>","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【普利制药：触及重大违法强制退市 1月7日起被实施“退市风险警示”】普利制药(300630.SZ)发布公告，公司因涉嫌信息披露违法违规，被中国证监会立案调查。公司于2025年1月4日收到中国证监会下发的《行政处罚事先告知书》。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【普利制药：触及重大违法强制退市 1月7日起被实施“退市风险警示”】普利制药(300630.SZ)发布公告，公司因涉嫌信息披露违法违规，被中国证监会立案调查。公司于2025年1月4日收到中国证监会下发的《行政处罚事先告知书》。\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">金融界</strong><span class=\"h-time small\">2025-01-05 16:23</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><div><span><a href=\"https://laohu8.com/S/300630\">普利制药</a></span>(300630.SZ)发布公告，公司因涉嫌信息披露违法违规，被中国证监会立案调查。公司于2025年1月4日收到中国证监会下发的《行政处罚事先告知书》。</div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://24h.jrj.com.cn/2025/01/05162347136287.shtml\">金融界</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/01/05162347136287.shtml","article_id":"2501940114","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501940114","pubTimestamp":1736065415,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"普利制药(300630.SZ)发布公告，公司因涉嫌信息披露违法违规，被中国证监会立案调查。公司于2025年1月4日收到中国证监会下发的《行政处罚事先告知书》。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300630":"*ST普利","BK0239":"医药制造"},"translate_title":"[Puli Pharmaceutical: Compulsory delisting for major violations will be implemented on January 7 as a \"delisting risk warning\"] Puli Pharmaceutical (300630. SZ) issued an announcement that the company was investigated by the China Securities Regulatory Commission for suspected information disclosure violations. The company received the \"Advance Notice of Administrative Penalties\" issued by the China Securities Regulatory Commission on January 4, 2025.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300630":1},"content_text":"普利制药(300630.SZ)发布公告，公司因涉嫌信息披露违法违规，被中国证监会立案调查。公司于2025年1月4日收到中国证监会下发的《行政处罚事先告知书》。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2501940114"}